|
 |
|
The 2011 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
This comprehensive seven-country report identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next ten years; examines trends in the U.S....
|
 |
|
$28500.00 |
| |
|
|
|
Future Cancer Diagnostics Market: Growth Opportunities and Business Expansion Strategies
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field....
|
|
|
$28500.00 |
| |
|
|
|
Gastric Cancer
Despite advances in surgery and the use of multimodality therapy, survival outcomes remain poor for gastric cancer patients. There is an urgent need for more effective therapies to improve survival rates in patients presenting with both localized and advanced disease....
|
|
|
$15200.00 |
| |
|
|
|
Top 20 Cancer Therapy Brands
The top 20 cancer therapies achieved sales of over $30 billion, or 75% of the cancer therapy market. The commercial success experienced by the key companies in the cancer therapy market makes the market extremely attractive to drug developers....
|
|
|
$15200.00 |
| |
|
|
|
Market and Product Forecasts: Colon Cancer
Introduction
The colon cancer pipeline has grown as pharmaceutical companies are attracted by the high incidence and success of other developers. Cytotoxics will remain an integral part of treatment, but with key brands expected to come off patent over the forecast period and the approval of new therapies, competition between targeted therapies in this lucrative indication is set to intensify....
|
|
|
$11400.00 |
| |
|
|
|
The 2011 US Cancer Diagnostics Market
This report presents a comprehensive analysis of the US cancer diagnostics market, including:- Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$8700.00 |
| |
|
|
|
Future US Cancer Diagnostics Market: Growth Opportunities and Business Expansion Strategies
This report presents a comprehensive analysis of the US cancer diagnostics market, including:
- Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$8700.00 |
| |
|
|
|
Licensing Opportunities in Cancer
Introduction
Licensing Opportunities in Cancer provides you with the 35 most promising oncology licensing candidates. To place these in context, the cancer market size and forecast overall growth to 2016 are detailed....
|
|
|
$7995.00 |
| |
|
|
|
The 2011 Japanese Cancer Diagnostics Market
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including:- Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$6700.00 |
| |
|
|
|
The 2011 French Cancer Diagnostics Market
This report presents a comprehensive analysis of the French cancer diagnostics market, including:- Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$5400.00 |
| |
|
|
|
The 2011 German Cancer Diagnostics Market
This report presents a comprehensive analysis of the German cancer diagnostics market, including:- Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$5400.00 |
| |
|
|
|
The 2011 Italian Cancer Diagnostics Market
This report presents a comprehensive analysis of the Italian cancer diagnostics market, including:- Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$5400.00 |
| |
|
|
|
The 2011 Spanish Cancer Diagnostics Market
This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including:- Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$5400.00 |
| |
|
|
|
The 2011 UK Cancer Diagnostics Market
This report presents a comprehensive analysis of the UK cancer diagnostics market, including:- Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e....
|
|
|
$5400.00 |
| |
|
|
|
The 2011 CA Tumor Markers: US, Europe, Japan
Test Volume, Sales Forecasts and Supplier Shares by Country
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field....
|
|
|
$4850.00 |
| |
|
|
|
Cell Surface Markers 2011: US, Europe, Japan
Forecasts by Test, Market Segment and Country
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies....
|
|
|
$4750.00 |
| |
|
|
|
The 2011 AFP Testing Market: US, Europe, Japan
Test Volume, Sales Forecasts and Supplier Shares by Country
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field....
|
|
|
$3850.00 |
| |
|
|
|
The 2011 Beta-2 Microglobulin: US, Europe, Japan
Test Volume, Sales Forecasts and Supplier Shares by Country
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field....
|
|
|
$3850.00 |
| |
|
|
|
|